Articles

Monitoring nighttime blood pressure identifies patients with type 1 diabetes who are at increased risk for kidney disease.

If obesity is the leading cause of type II diabetes, then why do thiazolidinediones (TZDs), the only available drugs that treats this form of diabetes, actually cause more weight gain?

Victorian scientists reveal strong evidence for a new therapeutic target in the fight against Type 2 Diabetes.

Findings from two studies by the US Centers for Disease Control and Prevention indicate that the prevalence of overweight and obesity in the US continues to increase.

Inhaled, rapid-acting, dry powder insulin (Exubera®) may be used as a convenient alternative to pre-prandial injections in patients with type 1 diabetes.

Increased nocturnal blood pressure may be a harbinger of microalbuminuria in patients with type 1 diabetes.

Decreased heart rate variability in diabetics appears to be an independent risk factor for mortality.

High-intensity weight training coupled with a moderate weight-loss program can help older men and women with type 2 diabetes to improve their blood sugar control and also boost their muscle strength and lean body mass, researchers report.

Obese individuals have delayed transcapillary transport of insulin to muscle tissue, 25 minutes slower, Swedish researchers report in the September issue of Diabetes.

Glucovance OK’ed to use with Thiazolidediones, which makes it a triple therapy.